Article Information
History
- June 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Chris Davis1,
- Nicola Logan1,
- Grace Tyson1,
- Richard Orton1,
- William Harvey1,
- John Haughney2,
- Jon Perkins2,
- The COVID-19 Genomics UK (COG-UK) Consortium#,
- Thomas P. Peacock3,
- Wendy S. Barclay3,
- Peter Cherepanov4,
- Massimo Palmarini1,
- Pablo R. Murcia1,
- Arvind H. Patel1,
- David L. Robertson1,
- Emma C. Thomson1,*,
- Brian J. Willett1,* and
- on behalf of the COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators
- 1MRC University of Glasgow Centre for Virus Research, University of Glasgow, UK, G61 1QH
- 2Clinical R&D, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK
- 3Department of Infectious Disease, Imperial College London, UK, W2 1PG
- 4The Francis Crick Institute, London, NW1 1AT, UK
- ↵*Corresponding authors: Tel: +44 1413302928, email: emma.thomson{at}glasgow.ac.uk, Tel: +44 1413303274, email: brian.willett{at}glasgow.ac.uk